Table 2.
Study | Pekmezaris et al, 2019 13 | Young et al, 2016 14 | Caldwell et al, 2005 16 | Dracup et al, 2014 15 | Lefler et al, 2018 17 |
---|---|---|---|---|---|
Was the study described as randomized, a randomized trial, a randomized clinical trial, or an randomized controlled trial? | Yes | Yes | Yes | Yes | Yes |
Was the method of randomization adequate (ie, use of randomly generated assignment)? | Yes | Yes | NR | Yes | NR |
Was the treatment allocation concealed (so that assignments could not be predicted)? | Yes | Yes | NR | Yes | NR |
Were study participants and providers blinded to treatment group assignment? | NR | No | NR | Yes | NR |
Were the people assessing the outcomes blinded to the participants' group assignments? | No | Yes | NR | Yes | NR |
Were the groups similar at baseline on important characteristics that could affect outcomes (eg, demographics, risk factors, comorbid conditions)? | Yes | No | Yes | Yes | NR |
Was the overall drop‐out rate from the study at end point 20% or lower of the number allocated to treatment? | Yes | Yes | NR | Yes | Yes |
Was the differential dropout rate (between treatment groups) at the end point 15 percentage points or lower? | Yes | Yes | NR | Yes | Yes |
Was there high adherence to the intervention protocols for each treatment group? | Yes | Yes | NR | Yes | Yes |
Were other interventions avoided or similar in the groups (eg, similar background treatments)? | Yes | Yes | NR | Yes | Yes |
Were outcomes assessed using valid and reliable measures, implemented consistently across all study participants? | Yes | Yes | No | Yes | Yes |
Did the authors report that the sample size was sufficiently large to be able to detect a difference in the main outcome between groups with at least 80% power? | No | Yes | No | Yes | No |
Were outcomes reported or subgroups analyzed prespecified (ie, identified before analyses were conducted)? | Yes | Yes | Yes | Yes | Yes |
Were all randomized participants analyzed in the group to which they were originally assigned (ie, did they use an intention‐to‐treat analysis?)? | Yes | No | No | Yes | No |
Quality | Fair | Fair | Poor | Good | Poor |
Limitations |
|
|
|
|
|
NR indicates not reported.